GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-828 Cr | ₹-265 Cr | ₹625 Cr | ₹1,109 Cr | ₹1,131 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-828 Cr |
| Mar2024 | ₹-265 Cr |
| Mar2023 | ₹625 Cr |
| Mar2022 | ₹1,109 Cr |
| Mar2021 | ₹1,131 Cr |
How is Cash Flow from Operating Activities of GLENMARK PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-828 Cr | Negative | |
| Mar2024 | ₹-265 Cr | Negative | |
| Mar2023 | ₹625 Cr | -43.59 | |
| Mar2022 | ₹1,109 Cr | -1.99 | |
| Mar2021 | ₹1,131 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,212.0 Cr | 3.5% | 3% | 40.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,050.0 Cr | -0.9% | -3.9% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,157.0 Cr | -0.4% | -7.6% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,531.0 Cr | -2% | -7.5% | 27.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,190.0 Cr | -1.5% | -9.3% | 3.8% | Stock Analytics | |
| CIPLA | ₹98,892.8 Cr | 1.7% | -8.3% | -16.8% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 3.5% |
3% |
40.1% |
| SENSEX | 4.8% |
-4.2% |
0.8% |
You may also like the below Video Courses